Axsome Therapeutics, Inc. stands as a biopharmaceutical firm dedicated to developing innovative treatments for central nervous system (CNS) conditions within the United States. The company’s portfolio features marketed products including Au…
HQ: New York City, NY, United States of Americawww.axsome.com
USD141.69-1.86%vs prev. close
Performance
1W
+11.22%
1M
-7.64%
3M
-32.44%
1Y
+2.49%
YTD
-20.95%
Valuation
P/E
—
EPS TTM
-3.03
Dividend yield
—
Size and risk
Market cap
$7.5B
Beta
0.83
Price history
AXSM price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Axsome Therapeutics
AXSM
Biotechnology
Mkt cap (USD bn)
7.5
P/E
—
Div yld
—
1W
+11.2%
1M
-7.6%
3M
-32.4%
6M
-37.8%
1Y
+2.5%
YTD
-20.9%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Axsome Therapeutics
AXSM
Biotechnology
7.5
—
—
+11.2%
-7.6%
-32.4%
-37.8%
+2.5%
-20.9%
Subscribe to Equity Analytics to compare AXSM with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.